[Treatment of childhood adrenocortical tumor].

about

[Treatment of childhood adrenocortical tumor].

Item

http://www.wikidata.org/entity/Q46917436

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

[Treatment of childhood adrenocortical tumor].

@en

[Treatment of childhood adrenocortical tumor].

@nl

type

Item

label

[Treatment of childhood adrenocortical tumor].

@en

[Treatment of childhood adrenocortical tumor].

@nl

prefLabel

[Treatment of childhood adrenocortical tumor].

@en

[Treatment of childhood adrenocortical tumor].

@nl

P1476

[Treatment of childhood adrenocortical tumor].

@en

P2093

Edson Michalkiewicz

http://www.w3.org/2001/XMLSchema#string

Izrail Cat

http://www.w3.org/2001/XMLSchema#string

Luiz de Lacerda Filho

http://www.w3.org/2001/XMLSchema#string

Mara Albonei Pianovski

http://www.w3.org/2001/XMLSchema#string

Margaret C S Boguszewski

http://www.w3.org/2001/XMLSchema#string

Romolo Sandrini

http://www.w3.org/2001/XMLSchema#string

Rosana Marques Pereira

http://www.w3.org/2001/XMLSchema#string

Susana Nesi França

http://www.w3.org/2001/XMLSchema#string

P2860

Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (mdr-1/P-glycoprotein) which is also expressed by adrenocortical carcinomas

Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.

An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma.

A case of adrenocortical carcinoma associated with recurrence after laparoscopic surgery.

Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p'DDD) levels on the treatment of patients with adrenocortical carcinoma.

Functioning adrenocortical neoplasms in children.

The effect of o,p'-DDD on adrenal steroid replacement therapy requirements.

Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients.

The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors.

Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry.

P304

747-752

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/S0004-27302005000500015

http://www.w3.org/2001/XMLSchema#string

P407

Amanung Portuges

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16444357

http://www.w3.org/2001/XMLSchema#string